Natalia Bello

789 total citations
31 papers, 504 citations indexed

About

Natalia Bello is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Natalia Bello has authored 31 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 10 papers in Hematology and 10 papers in Immunology. Recurrent topics in Natalia Bello's work include Rheumatoid Arthritis Research and Therapies (15 papers), Autoimmune and Inflammatory Disorders Research (10 papers) and Systemic Lupus Erythematosus Research (10 papers). Natalia Bello is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (15 papers), Autoimmune and Inflammatory Disorders Research (10 papers) and Systemic Lupus Erythematosus Research (10 papers). Natalia Bello collaborates with scholars based in Spain, United States and United Kingdom. Natalia Bello's co-authors include Esperanza Naredo, Luis Carreño, I. Monteagudo, Juan Carlos Nieto‐González, Carlos González, Lara Valor, Gerd R Burmester, Peter C. Taylor, María Montoro and Adrien Etcheto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Natalia Bello

29 papers receiving 500 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Natalia Bello 388 144 124 57 49 31 504
Bernd Raffeiner 319 0.8× 195 1.4× 112 0.9× 69 1.2× 54 1.1× 29 630
Murat Turgay 217 0.6× 115 0.8× 53 0.4× 112 2.0× 60 1.2× 69 540
Andreas Gerards 425 1.1× 132 0.9× 172 1.4× 34 0.6× 28 0.6× 19 516
Berkan Armağan 190 0.5× 164 1.1× 100 0.8× 60 1.1× 100 2.0× 109 566
L. Zakraoui 229 0.6× 88 0.6× 79 0.6× 64 1.1× 67 1.4× 57 409
Michael Sejer Hansen 648 1.7× 245 1.7× 257 2.1× 48 0.8× 66 1.3× 11 732
Şenol Kobak 341 0.9× 114 0.8× 66 0.5× 89 1.6× 74 1.5× 87 768
Şule Apraş Bilgen 224 0.6× 155 1.1× 100 0.8× 58 1.0× 89 1.8× 66 495
Alejandro Olivé 372 1.0× 63 0.4× 58 0.5× 83 1.5× 143 2.9× 46 596
Josiane Bourré‐Tessier 265 0.7× 118 0.8× 49 0.4× 82 1.4× 52 1.1× 28 499

Countries citing papers authored by Natalia Bello

Since Specialization
Citations

This map shows the geographic impact of Natalia Bello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalia Bello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalia Bello more than expected).

Fields of papers citing papers by Natalia Bello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalia Bello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalia Bello. The network helps show where Natalia Bello may publish in the future.

Co-authorship network of co-authors of Natalia Bello

This figure shows the co-authorship network connecting the top 25 collaborators of Natalia Bello. A scholar is included among the top collaborators of Natalia Bello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalia Bello. Natalia Bello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lebwohl, Mark, Atul Deodhar, Sergio Schwartzman, et al.. (2025). Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events. Dermatology and Therapy. 15(1). 161–188. 2 indexed citations
2.
3.
Taylor, Peter C., Daniel Aletaha, Raimón Sanmartí, et al.. (2024). Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis up to 6.5 years of treatment: results of a long-term study. Lara D. Veeken. 63(10). 2799–2809. 2 indexed citations
4.
5.
Keller, Guillermo Alberto, et al.. (2023). Polypharmacy and Drug Interactions in the COVID-19 Pandemic. SHILAP Revista de lepidopterología. 124(4). 392–412. 1 indexed citations
6.
7.
Bello, Natalia, Kristin J. Meyers, Jennifer K. Workman, José S Marcano Belisario, & Ricard Cervera. (2022). Systematic Literature Review and Meta-analysis of Venous Thromboembolism Events in Systemic Lupus Erythematosus. Rheumatology and Therapy. 10(1). 7–34. 14 indexed citations
8.
Dörner, Thomas, Edward M Vital, Sarah Ohrndorf, et al.. (2022). A Narrative Literature Review Comparing the Key Features of Musculoskeletal Involvement in Rheumatoid Arthritis and Systemic Lupus Erythematosus. Rheumatology and Therapy. 9(3). 781–802. 15 indexed citations
9.
Freites, D., Alfredo Madrid-García, Leticia León, et al.. (2021). Factors Associated with Health-Related Quality of Life in Psoriatic Arthritis Patients: A Longitudinal Analysis. Rheumatology and Therapy. 8(3). 1341–1354. 10 indexed citations
10.
Taylor, Peter C., Tsutomu Takeuchi, Gerd R Burmester, et al.. (2021). Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database. Annals of the Rheumatic Diseases. 81(3). 335–343. 102 indexed citations
11.
Birt, Julie, Paul Swinburn, Natalia Bello, et al.. (2021). Patient Experiences, Satisfaction, and Expectations with Current Systemic Lupus Erythematosus Treatment: Results of the SLE-UPDATE Survey. Rheumatology and Therapy. 8(3). 1189–1205. 10 indexed citations
12.
Naredo, Esperanza, I. Janta, Ofelia Baniandrés, et al.. (2018). To what extend is nail ultrasound discriminative between psoriasis, psoriatic arthritis and healthy subjects?. Rheumatology International. 39(4). 697–705. 20 indexed citations
13.
Bello, Natalia, et al.. (2016). Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis. Arthritis Research & Therapy. 18(1). 42–42. 54 indexed citations
14.
Perazzi, Beatriz, et al.. (2016). Increase in IS 256 transposition in invasive vancomycin heteroresistant Staphylococcus aureus isolate belonging to ST100 and its derived VISA mutants. Infection Genetics and Evolution. 43. 197–202. 11 indexed citations
15.
Janta, I., Michelle Hinojosa, Juan Carlos Nieto‐González, et al.. (2016). Structural damage in rheumatoid arthritis: comparison between tendon damage evaluated by ultrasound and radiographic damage. Lara D. Veeken. 55(6). 1042–1046. 14 indexed citations
16.
Janta, I., Lara Valor, María Montoro, et al.. (2015). Comparison between full and tapered dosages of biologic therapies in psoriatic arthritis patients: clinical and ultrasound assessment. Clinical Rheumatology. 34(5). 935–942. 15 indexed citations
17.
Naredo, Esperanza, Lara Valor, Inmaculada de la Torre, et al.. (2015). Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis. Lara D. Veeken. 54(8). 1408–1414. 90 indexed citations
18.
Janta, I., Lara Valor, Inmaculada de la Torre, et al.. (2015). Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?. Rheumatology International. 36(3). 387–396. 12 indexed citations
19.
Naredo, Esperanza, Michelle Hinojosa, Lara Valor, et al.. (2014). Does ultrasound-scored synovitis depend on the pharmacokinetics of subcutaneous anti-TNF agents in patients with rheumatoid arthritis?. Lara D. Veeken. 53(11). 2088–2094. 3 indexed citations
20.
Janta, I., Esperanza Naredo, Inmaculada de la Torre, et al.. (2013). Patient self-assessment and physician's assessment of rheumatoid arthritis activity: which is more realistic in remission status? A comparison with ultrasonography. Lara D. Veeken. 52(12). 2243–2250. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernd Raffeiner Breakdown of academic impact, for papers by Murat Turgay Breakdown of academic impact, for papers by Andreas Gerards Breakdown of academic impact, for papers by Berkan Armağan Breakdown of academic impact, for papers by L. Zakraoui Breakdown of academic impact, for papers by Michael Sejer Hansen Breakdown of academic impact, for papers by Şenol Kobak Breakdown of academic impact, for papers by Şule Apraş Bilgen Breakdown of academic impact, for papers by Alejandro Olivé Breakdown of academic impact, for papers by Josiane Bourré‐Tessier
Rankless by CCL
2026